SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nova Leap Health Corp. (NVLPF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NVLPF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.70
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.37
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.04 |
$39.99K |
$-489.52K |
-1224.1% |
| 2017 |
$-0.04 |
$1.06M |
$-851.61K |
-80.4% |
| 2018 |
$-0.02 |
$10.36M |
$-961.27K |
-9.3% |
| 2019 |
$-0.02 |
$17.4M |
$-1.06M |
-6.1% |
| 2020 |
$0.02 |
$17.31M |
$1.26M |
7.3% |
| 2021 |
$0.02 |
$21.28M |
$1.76M |
8.3% |
| 2022 |
$-0.01 |
$28.21M |
$-835.75K |
-3% |
| 2023 |
$-0.01 |
$26.18M |
$-1.05M |
-4% |
| 2024 |
$0.02 |
$25.76M |
$1.38M |
5.4% |
| 2025 |
$0.00 |
$32.02M |
$-193.19K |
-0.6% |
